Results 101 to 110 of about 116,073,120 (283)
IFN-gamma impairs release of IL-8 by IL-1beta-stimulated A549 lung carcinoma cells [PDF]
, 2008 Background Production of interferon (IFN)-gamma is key to efficient anti-tumor immunity. The present study was set out to investigate effects of IFNgamma on the release of the potent pro-angiogenic mediator IL-8 by human A549 lung carcinoma cells ...
Bernhard Zwissler +15 more
core +2 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Patients with chronic kidney disease undergoing hemodialysis commonly experience reduced physical function, fatigue, poor sleep quality, and impaired health‐related quality of life. Intradialytic exercise has been proposed as a non‐pharmacological strategy to improve these outcomes.
Klebson da Silva Almeida +6 more
wiley +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction Peritoneal dialysis (PD) is an established home‐based kidney replacement therapy (KRT), but its uptake remains low in Japan. We evaluated whether individualized education in a dedicated outpatient clinic was associated with the initiation of PD.
Yasuko Ito +7 more
wiley +1 more source
IL-2-dependent expansion of Tregs during FV infection.
, 2018 Depicted in brown are Treg activation events dependent on FV infection. No direct interactions between viral antigens and Tregs are required. Depicted in gray are required homeostatic signaling events for FV-induced Treg expansion.
Ulf Dittmer (85326) +2 more
core +1 more source
TREATMENT OF CHRONIC CHAGASIC PATIENTS: IS KILLING THE PARASITE THE ONLY OPTION?
European Medical Journal Cardiology, 2018 Chagas disease is a tropical illness characterised by arrhythmias, heart failure, and eventually death. In approximately 10–30% of patients, chronic disease appears 10–30 years after infection onset.
Héctor O. Rodríguez-Angulo
doaj
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng +3 more
wiley +1 more source
IL-1β-induced ERK1/2 phosphorylation and its inhibition by an ERK1/2 inhibitor.
, 2019 In dermal fibroblasts treated with 100 pM IL-1β for 0–60 min, ERK1/2 phosphorylation (p-ERK1/2) was observed in a time-dependent manner (a, b). IL-1β had no effect on total ERK1/2 (t-ERK1/2) expression (a).
Taku Kitanaka (3350276) +7 more
core +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Instruction Tenapanor potentially affects fluid volume and blood pressure. This study explored its effects on these parameters in patients undergoing peritoneal dialysis (PD). Methods We conducted a single‐arm, prospective observational study that enrolled 10 patients on PD with hyperphosphatemia who were newly initiated on tenapanor.
Shun Yoshida +11 more
wiley +1 more source
Regulation of IL-18 binding protein by IFN-gamma [PDF]
, 2003 In this study we investigated the regulation of IL-18BPa by IFN-y in the context of colon cancer and human autoimmune diseases. IL-18BPa is a naturally occuring inhibitor that counteracts IL-18 bioactivity.
Paulukat, Jens
core
IL-2 level in the aqueous humor.
, 2018 ELISA test demonstrated that IL-2 concentration was significantly increased in the untreated group at 3 weeks, and CsA DDS treatment more effectively decreased the level of IL-2 in the aqueous humors at all time-points.
Ting Liu (45625) +6 more
core +1 more source